Thrombotic Stroke occurs when a blood clot formed in an artery supplying blood to the brain, blocking the flow of oxygen and other vital nutrients. This type of stroke is very serious and can lead to death or permanent disability if not treated quickly. The most common cause of a thrombotic stroke is atherosclerosis, a type of artery disease. Atherosclerosis occurs when fatty deposits, or plaque, accumulate on the walls of arteries, narrowing them and eventually blocking the artery completely. This blockage is called a thrombus. If this thrombus restricts or completely cuts off the flow of blood, a thrombotic stroke can occur. Other risk factors for thrombotic stroke include high cholesterol, high blood pressure, diabetes, smoking, and abnormal heart rhythms. Too little physical activity and unhealthy eating habits are also thought to increase the risk of a thrombotic stroke. The symptoms of a thrombotic stroke may include sudden numbness or weakness in the face, arms, or legs; confusion; difficulty understanding or speaking; loss of balance or coordination; trouble walking; sudden trouble seeing; or a severe headache. Treatment of a thrombotic stroke should be done as quickly as possible and includes medications to help dissolve the blood clot, such as tissue plasminogen activator (tPA). Additional medications may also be prescribed to lower the risk of future strokes. Surgery can also be performed to remove the clot if medications are not effective. Preventing a thrombotic stroke means managing lifestyle and health risks. Eating a heart-healthy diet, exercising regularly, quitting smoking, and having regular check-ups can all help reduce the risk of thrombotic stroke. Additionally, medications such as blood thinners may be prescribed to prevent blood clots from forming.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States